help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacoby, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacoby, D. B.
American Journal of Respiratory Cell and Molecular Biology. Vol. 28, pp. 138-141, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.F260


Perspective

Airway Neural Plasticity

The Nerves They Are A-Changin'

David B. Jacoby

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Address correspondence to: David B. Jacoby, M.D., Division of Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224. E-mail: djacoby{at}jhmi.edu

Abbreviations: nerve growth factor, NGF • neurotrophin receptor, NTR • vanilloid receptor-1, VR1


    Introduction
 Top
 Introduction
 Neurotrophins and Neurotrophin...
 Complex Effects of Neurotrophins...
 Neurotrophins in Neural...
 Changes in Capsaicin Receptors,...
 References
 
Bronchoconstriction is mediated by two anatomically and functionally distinct neural systems. Cholinergic fibers arise in parasympathetic ganglia in the airway walls, and cause bronchoconstriction by releasing acetylcholine onto smooth muscle M3 muscarinic receptors. Noncholinergic fibers arise in sensory ganglia in the vagus, and contribute to bronchoconstriction both by providing the afferent limb of a reflex arc and by releasing tachykinins onto neurokinin receptors on the smooth muscle. These systems allow the airway to respond both to exogenous irritants and to endogenous mediators. However, changes in the structure and function of the nerves themselves in response to changing conditions, a phenomenon known as neural plasticity, may also contribute to the pathophysiology of airway diseases.

Neural plasticity has been recognized and studied in relation to pain, and multiple mechanisms have been identified (see Ref. 1 for review). Changes may be rapid and reversible, as for example changes in excitability after exposure of the neurons to sensitizing agents, including prostaglandin E2, 5-hydroxytryptamine, bradykinin, and neurotrophins. Changes may also be longer lasting, and involve increases in expression of transmitters, receptors, or ion channels, or changes in the structure of the neurons themselves. Such long-term changes are seen during inflammation, and include increased expression of tachykinins, the capsaicin receptor VR1, and sensory neuron–specific sodium channels. All these changes may potentiate pain-sensing pathways.

In this issue of the AJRCMB, Kerzel and colleagues report that inhalation of antigen increases capsaicin-induced bronchoconstriction in wild-type mice, but not in mice with a homozygous deletion of p75NTR, one of the neurotrophin receptors (2). This adds to a growing body of literature suggesting that neurotrophins are involved in airway neural plasticity, as has previously been shown in sensory nerves elsewhere.


    Neurotrophins and Neurotrophin Receptors
 Top
 Introduction
 Neurotrophins and Neurotrophin...
 Complex Effects of Neurotrophins...
 Neurotrophins in Neural...
 Changes in Capsaicin Receptors,...
 References
 
The neurotrophins are a family of growth factors that includes nerve growth factor (NGF), brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4. Several lines of evidence suggest their involvement in airway disease. Serum NGF levels are elevated in patients with allergic diseases and with asthma (3). Furthermore, exogenous NGF causes airway hyperresponsiveness in guinea pigs (4). NGF-induced hyperresponsiveness is prevented by blocking the substance P receptor (NK-1R), suggesting that tachykinins are involved.

Neurotrophins signal via two sets of receptors. The Trk family of receptor tyrosine kinases bind neurotrophins with high affinity: NGF binds preferentially to TrkA, brain-derived neurotrophic factor and neurotrophin-3 bind to TrkB, and neurotrophin-4 binds to TrkC. In addition, all the neurotrophins bind with similar but lower affinity to a second receptor, p75NTR. This receptor is a member of the tumor necrosis factor superfamily of receptors.


    Complex Effects of Neurotrophins in Neuron Survival and Death
 Top
 Introduction
 Neurotrophins and Neurotrophin...
 Complex Effects of Neurotrophins...
 Neurotrophins in Neural...
 Changes in Capsaicin Receptors,...
 References
 
In general, Trk receptors promote neuron survival, whereas p75NTR promotes cell death. Effector proteins associated with cell death, including caspases, Jun N-terminal kinase, and p53, are all activated by p75NTR (5, 6). These effects may be important in neurodegenerative diseases, as p75NTR is activated by prion protein fragment PrP (26–106) (7), which is neurotoxic, as well as by the Aß peptide of amyloid precursor protein, found in Alzheimer's disease (8). Increased expression of p75NTR may be important in neuron death in amyotrophic lateral sclerosis (9). Furthermore, pro-NGF (which is also secreted) binds with higher affinity to p75NTR and binds poorly to Trk, again favoring cell death (10). However, p75NTR also activates nuclear factor (NF)-{kappa}B (11), probably via tumor necrosis factor receptor–associated factor-6, and NF-{kappa}B promotes neuron survival. Furthermore, p75NTR interacts directly with Trk, increasing the binding affinity of Trk for neurotrophins 100-fold (12), and this effect may also promote survival. Thus, the overall effect of neurotrophins on cell survival depends on the receptors present, interactions among receptors, the specific neurotrophin secreted, and the predominant signal transduction pathway activated.


    Neurotrophins in Neural Plasticity
 Top
 Introduction
 Neurotrophins and Neurotrophin...
 Complex Effects of Neurotrophins...
 Neurotrophins in Neural...
 Changes in Capsaicin Receptors,...
 References
 
P75NTR also participates in neural plasticity. Axon elongation is increased by stimulating the p75NTR (13), a result of decreased activation of the small G-protein Rho (which in its active state inhibits elongation via effects on the cytoskeleton). p75NTR can also control axon elongation by interacting with components of myelin and another receptor, the Nogo receptor (14). Neurotrophins also affect synaptic function. p75NTR is involved in neurotrophin-stimulated acetylcholine release by cardiac sympathetic neurons, whereas Trk increases norepinephrine release (15). These effects may be linked to hydrolysis of sphingomyelin, which is stimulated by p75NTR (16). Both Trk and p75NTR increase intracellular calcium (17) and are involved in activity-dependent synaptic plasticity in the hippocampus.


    Changes in Capsaicin Receptors, Tachykinins, and Sodium Channels
 Top
 Introduction
 Neurotrophins and Neurotrophin...
 Complex Effects of Neurotrophins...
 Neurotrophins in Neural...
 Changes in Capsaicin Receptors,...
 References
 
Capsaicin acts on airway sensory nerves by activating vanilloid receptors, causing release of tachykinins. Tachykinins stimulate bronchoconstriction directly, and stimulate gland secretion and epithelial ion transport, mediate neurogenic inflammation, and facilitate synaptic transmission in the nucleus of the tractus solitarius (potentially augmenting airway reflexes [18]). Stimulation of sensory fibers via this receptor may also initiate reflex cholinergic bronchoconstriction (19).

The vanilloid receptor VR1 is a nonspecific cation channel (20). This receptor responds not only to capsaicin, but also to some noxious stimuli, including heat and acid (20). Expression of this receptor is increased in sensory neurons in the presence of inflammation (21). This causes heat hyperalgesia. Inflammation-induced increase in VR1 protein is blocked by antibodies to NGF, and depends on NGF-mediated phosphorylation of p38 (22). NGF also increases the function of existing VR1 receptors (23).

Airway inflammation may also increase the expression of tachykinins in subpopulations of sensory nerve fibers. Under normal circumstances, tachykinins are expressed by small, slow conducting, nonmyelinated C-fibers in the airways. After antigen inhalation (24, 25) or viral infection (26), larger A{delta}-fibers, which normally do not express tachykinins, begin to express this class of neurotransmitter (Figure 1). Similar increases in tachykinin expression can be induced by the direct application of NGF to the airway wall (27). These A{delta} fibers do not express VR1 receptors, and are not sensitive to capsaicin (25). However, they do respond to touch, and the expression of tachykinins in these fibers has the potential to make the airway respond to touch with tachykinin-mediated responses usually seen after application of capsaicin. Similar changes in somatic sensory nerves lead to the perception of pain in response to touch, a phenomenon known as allodynia.



View larger version (105K):
[in this window]
[in a new window]
 
Figure 1. Expression of tachykinins in the nodose ganglion of the vagus is increased in antigen challenged guinea pigs. Left panel: immunostaining using an antibody that recognizes substance P and neurokinin A demonstrates positive staining in 48% of ganglion cells 24 h after inhalation of antigen. Right panel: In control animal, only 25% of ganglion cells stain positive for SP/NKA. Scale bar = 50 µM. Reprinted with permission from Ref. 23.

 
The ability of inflammatory stimuli to induce expression of tachykinins may not be limited to sensory neurons. Wu and coworkers recently demonstrated that interleukin-1ß can induce expression of tachykinins in the cholinergic neurons of the airway parasympathetic ganglia (28). As interleukin-1ß can induce expression of NGF (29), it is possible that pathways similar to those thought to be important in sensory neurons are also involved in the parasympathetic ganglia.

Sensory nerve expression of the neuron-specific sodium channel SNS is also increased by NGF (3032). This may increase sodium currents and increase excitability.

Thus, neural plasticity in the inflamed airway might both increase the synthesis of tachykinins and facilitate their release. As conditions causing airway inflammation may also decrease the activity of neutral endopeptidase (33, 34), an enzyme that inactivates tachykinins, the effects of tachykinins may be further potentiated. Airway inflammation also causes loss of function and decreased expression of inhibitory M2 muscarinic receptors on the cholinergic nerves (35). This increases the release of acetylcholine, increasing the reflex bronchoconstriction initiated by hypersensitive sensory nerves.

Thus both afferent and efferent limbs of the reflex are affected by neural plasticity, and may contribute to the increased airway response to capsaicin described by Kerzel and colleagues. NGF may be involved both directly, changing sensory nerve structure and function, and indirectly by promoting airway inflammation.

What is the source of the NGF in this system? Although NGF is produced by a wide variety of tissues, the association of the observed changes with inflammation makes leukocytes attractive candidates. It is widely accepted that airway inflammation is important in the pathogenesis of asthma and other airway diseases. Perhaps more relevant to plasticity of airway nerves is the finding that the airway nerves are inflamed in patients with asthma (36). In patients dying of acute asthma, eosinophils are clustered along the airway nerves (Figure 2), with extracellular eosinophil granule proteins demonstrating that the eosinophils were activated (36). Likewise, in antigen-sensitized guinea pigs and rats, eosinophils are selectively recruited to the airway nerves (Figure 2). Activation of these eosinophils, as occurs after antigen challenge and after viral infections (37), releases proteins that may affect the function of vagal efferents. As activated eosinophils are known to synthesize and release NGF (38), it is tempting to speculate that these eosinophils, or other inflammatory cells in the nerves, mediate the neural plasticity in airway disease.



View larger version (130K):
[in this window]
[in a new window]
 
Figure 2. Eosinophilic inflammation of the airway nerves in asthma (A and C) and in antigen-challenged guinea pigs (B and D). (A) Eosinophils cluster around an airway nerve bundle in a patient with fatal asthma. Nerves stain black with an antibody to the nerve-specific protein PGP9.5, eosinophils stain red with an antibody to major basic protein. (B) Eosinophils cluster around (and within) a nerve bundle in the airway of an antigen-challenged guinea pig, stained with hematoxylin and eosin. (C) Eosinophils (red) line up along an airway nerve fiber (black) in a patient with fatal asthma. (D) Eosinophils (red) line up along an airway nerve fiber (brown, stained for cholinesterase) in an antigen-challenged guinea pig. Reprinted with permission from Ref. 35.

 
Conversely, eosinophils and other leukocytes express receptors for NGF (39). Thus the decrease in airway inflammation in p75NGR-/- mice may have multiple explanations. Lack of response to NGF in leukocytes may inhibit their migration into the airways. Lack of response to NGF in the nerves may decrease the expression and release of tachykinins, which normally may participate in recruitment and activation of inflammatory cells after antigen challenge. Furthermore, deletion of p75NTR is known to decrease somatic sensory innervation (40). It is unknown whether this effect extends to the airway.

Thus, neural plasticity can participate in the functional changes seen in the inflamed airway. Recruitment of inflammatory cells to the airway, and to the nerves themselves, as seen in asthma and in antigen-sensitized animals, provides a source of neurotrophins, which are prime candidates as mediators of neural plasticity. Neurotrophins can increase tachykinin expression in both sensory and cholinergic neurons. Neurotrophins may also increase tachykinin release via multiple effects, including increased VR1 expression and VR1 function, and increased expression of neuronal sodium channels. Studying the mechanisms and consequences of airway neural plasticity will elucidate the links among inflammation, hyperresponsiveness, and asthma.


    Acknowledgments
 
This article was funded by NIH HL54659 and HL61013. The author thanks Drs. Allison Fryer and Maureen Horton for comments.

Received in original form December 13, 2002


    References
 Top
 Introduction
 Neurotrophins and Neurotrophin...
 Complex Effects of Neurotrophins...
 Neurotrophins in Neural...
 Changes in Capsaicin Receptors,...
 References
 

  1. Woolf, C. J., and M. W. Salter. 2000. Neuronal plasticity: increasing the gain in pain. Science 288:1765–1769.[Abstract/Free Full Text]
  2. Kerzel, S., G. Päth, W. A. Nockher, D. Quarcoo, U. Raap, D. A. Groneberg, Q. T. Dinh, A. Fischer, A. Braun, and H. Renz. 2003. Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. Am. J. Respir. Cell Mol. Biol. 28:170–178.[Abstract/Free Full Text]
  3. Bonini, S., A. Lambiase, F. Angelucci, L. Magrini, L. Manni, and L. Aloe. 1996. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc. Natl. Acad. Sci. USA 93:10955–10960.[Abstract/Free Full Text]
  4. de Vries, A., M. C. Dessing, F. Engels, P. A. Henricks, and F. P. Nijkamp. 1999. Nerve growth factor induces a neurokinin-1 receptor–mediated airway hyperresponsiveness in guinea pigs. Am. J. Respir. Crit. Care Med. 159:1541–1544.[Abstract/Free Full Text]
  5. Aloyz, R. S., S. X. Bamji, C. D. Pozniak, J. G. Toma, J. Atwal, D. R. Kaplan, and F. D. Miller. 1998. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell Biol. 143:1691–1703.[Abstract/Free Full Text]
  6. Troy, C. M., J. E. Friedman, and W. J. Friedman. 2002. Mechanisms of p75-mediated death of hippocampal neurons: role of caspases. J. Biol. Chem. 277:34295–34302.[Abstract/Free Full Text]
  7. Della-Bianca, V., F. Rossi, U. Armato, I. Dal-Pra, C. Costantini, G. Perini, V. Politi, and G. Della Valle. 2001. Neurotrophin p75 receptor is involved in neuronal damage by prion peptide-(106–126). J. Biol. Chem. 276:38929–38933.[Abstract/Free Full Text]
  8. Yaar, M., S. Zhai, P. F. Pilch, S. M. Doyle, P. B. Eisenhauer, R. E. Fine, and B. A. Gilchrest. 1997. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J. Clin. Invest. 100:2333–2340.[Medline]
  9. Lowry, K. S., S. S. Murray, C. A. McLean, P. Talman, S. Mathers, E. C. Lopes, and S. S. Cheema. 2001. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2:127–134.[CrossRef][Medline]
  10. Lee, R., P. Kermani, K. K. Teng, and B. L. Hempstead. 2001. Regulation of cell survival by secreted proneurotrophins. Science 294:1945–1948.[Abstract/Free Full Text]
  11. Kuner, P., R. Schubenel, and C. Hertel. 1998. Beta-amyloid binds to p75NTR and activates NFkappaB in human neuroblastoma cells. J. Neurosci. Res. 54:798–804.[CrossRef][Medline]
  12. Hempstead, B. L., D. Martin-Zanca, D. R. Kaplan, L. F. Parada, and M. V. Chao. 1991. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350:678–683.[CrossRef][Medline]
  13. Yamashita, T., K. L. Tucker, and Y. A. Barde. 1999. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 24:585–593.[CrossRef][Medline]
  14. Wang, K. C., J. A. Kim, R. Sivasankaran, R. Segal, and Z. He. 2002. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420:74–78.[CrossRef][Medline]
  15. Lockhart, S. T., G. G. Turrigiano, and S. J. Birren. 1997. Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. J. Neurosci. 17:9573–9582.[Abstract/Free Full Text]
  16. Dobrowsky, R. T., and B. D. Carter. 1998. Coupling of the p75 neurotrophin receptor to sphingolipid signaling. Ann. N. Y. Acad. Sci. 845:32–45.[Abstract/Free Full Text]
  17. Numakawa, T., N. Takei, S. Yamagishi, N. Sakai, and H. Hatanaka. 1999. Neurotrophin-elicited short-term glutamate release from cultured cerebellar granule neurons. Brain Res. 842:431–438.[CrossRef][Medline]
  18. Mutoh, T., A. C. Bonham, and J. P. Joad. 2000. Substance P in the nucleus of the solitary tract augments bronchopulmonary C fiber reflex output. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:R1215–R1223.[Abstract/Free Full Text]
  19. Mazzone, S. B., and B. J. Canning. 2002. Synergistic interactions between airway afferent nerve subtypes mediating reflex bronchospasm in guinea pigs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283:R86–R98.[Abstract/Free Full Text]
  20. Caterina, M. J., M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine, and D. Julius. 1997. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824.[CrossRef][Medline]
  21. Itoh, M., I. Takasaki, T. Andoh, H. Nojima, M. Tominaga, and Y. Kuraishi. 2001. Induction by carrageenan inflammation of prepronociceptin mRNA in VR1-immunoreactive neurons in rat dorsal root ganglia. Neurosci. Res. 40:227–233.[CrossRef][Medline]
  22. Ji, R. R., T. A. Samad, S. X. Jin, R. Schmoll, and C. J. Woolf. 2002. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57–68.[CrossRef][Medline]
  23. Chuang, H. H., E. D. Prescott, H. Kong, S. Shields, S. E. Jordt, A. I. Basbaum, M. V. Chao, and D. Julius. 2001. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411:957–962.[CrossRef][Medline]
  24. Fischer, A., G. P. McGregor, A. Saria, B. Philippin, and W. Kummer. 1996. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J. Clin. Invest. 98:2284–2291.[Medline]
  25. Myers, A. C., R. Kajekar, and B. J. Undem. 2002. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L775–L781.[Abstract/Free Full Text]
  26. Carr, M. J., D. D. Hunter, D. B. Jacoby, and B. J. Undem. 2002. Expression of tachykinins in nonnociceptive vagal afferent neurons during respiratory viral infection in guinea pigs. Am. J. Respir. Crit. Care Med. 165:1071–1075.[Abstract/Free Full Text]
  27. Hunter, D. D., A. C. Myers, and B. J. Undem. 2000. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am. J. Respir. Crit. Care Med. 161:1985–1990.[Abstract/Free Full Text]
  28. Wu, Z. X., B. E. Satterfield, J. S. Fedan, and R. D. Dey. 2002. Interleukin-1beta-induced airway hyperresponsiveness enhances substance P in intrinsic neurons of ferret airway. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L909–L917.[Abstract/Free Full Text]
  29. Fox, A. J., H. J. Patel, P. J. Barnes, and M. G. Belvisi. 2001. Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases. Eur. J. Pharmacol. 424:159–162.[CrossRef][Medline]
  30. Omri, G., and H. Meiri. 1990. Characterization of sodium currents in mammalian sensory neurons cultured in serum-free defined medium with and without nerve growth factor. J. Membr. Biol. 115:13–29.[CrossRef][Medline]
  31. Lesser, S. S., T. M. Holmes, A. J. Pittman, and D. C. Lo. 1999. Induction of electrical excitability by NGF requires autocrine action of a CNTF-like factor. Mol. Cell. Neurosci. 14:169–179.[CrossRef][Medline]
  32. Fjell, J., T. R. Cummins, B. M. Davis, K. M. Albers, K. Fried, S. G. Waxman, and J. A. Black. 1999. Sodium channel expression in NGF-overexpressing transgenic mice. J. Neurosci. Res. 57:39–47.[CrossRef][Medline]
  33. Dusser, D. J., D. B. Jacoby, T. D. Djokic, I. Rubinstein, D. B. Borson, and J. A. Nadel. 1989. Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase. J. Appl. Physiol. 67:1504–1511.[Abstract/Free Full Text]
  34. Sheppard, D., J. E. Thompson, L. Scypinski, D. Dusser, J. A. Nadel, and D. B. Borson. 1988. Toluene diisocyanate increases airway responsiveness to substance P and decreases airway neutral endopeptidase. J. Clin. Invest. 81:1111–1115.
  35. Fryer, A. D., D. J. Adamko, B. L. Yost, and D. B. Jacoby. 1999. Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung. Life Sci. 64:449–455.[CrossRef][Medline]
  36. Costello, R. W., B. H. Schofield, G. M. Kephart, G. J. Gleich, D. B. Jacoby, and A. D. Fryer. 1997. Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am. J. Physiol. 273:L93–103.[Abstract/Free Full Text]
  37. Adamko, D. J., B. L. Yost, G. J. Gleich, A. D. Fryer, and D. B. Jacoby. 1999. Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection: eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects. J. Exp. Med. 190:1465–1478.[Abstract/Free Full Text]
  38. Kobayashi, H., G. J. Gleich, J. H. Butterfield, and H. Kita. 2002. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 99:2214–2220.[Abstract/Free Full Text]
  39. Carr, M. J., D. D. Hunter, and B. J. Undem. 2001. Neurotrophins and asthma. Curr. Opin. Pulm. Med. 7:1–7.[CrossRef][Medline]
  40. Lee, K. F., E. Li, L. J. Huber, S. C. Landis, A. H. Sharpe, M. V. Chao, and R. Jaenisch. 1992. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69:737–749.[CrossRef][Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacoby, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacoby, D. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society.